✦ LIBER ✦

Cysteine derivatives with reactive groups as potential antitumor agents

✍ Scribed by Paul, B.; Korytnyk, W.

Book ID: 121338979
Publisher: American Chemical Society
Year: 1976
Tongue: English
Weight: 864 KB
Volume: 19
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm00230a004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel naphthalimide polyamine derivative

Novel naphthalimide polyamine derivatives as potential antitumor agents

✍ Robert Seliga, Martina Pilatova, Marek Sarissky… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 509 KB

Synthesis of sesquiterpene derivatives a

Synthesis of sesquiterpene derivatives as potential antitumor agents; Elemane derivatives

✍ Bo Gil Choi; Eun Yee Kwak; Byung Ho Chung; Won Jea Cho; Seung Hoon Cheon 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 300 KB

Carbonylacrylic derivatives as potential

Carbonylacrylic derivatives as potential antimicrobial agents. Correlations between activity and reactivity toward cysteine

✍ Dal Pozzo, Alma; Acquasaliente, Maurizio; Donzelli, Giovanni; De Maria, Paolo; N 📂 Article 📅 1987 🏛 American Chemical Society 🌐 English ⚖ 586 KB

Design and synthesis of isoindoloquinoli

Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents

✍ Heesoon Lee; llyeong Jeong; Sung-ll Yang 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 418 KB

Novel 3-Benzoyl-2-piperazinylquinoxaline

Novel 3-Benzoyl-2-piperazinylquinoxaline Derivatives as Potential Antitumor Agents.

✍ Sandra Piras; Mario Loriga; Antonio Carta; Giuseppe Paglietti; M. Paola Costi; S 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Novel 3-benzoyl-2-piperazinylquinoxaline

Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents

✍ Sandra Piras; Mario Loriga; Antonio Carta; Giuseppe Paglietti; M. Paola Costi; S 📂 Article 📅 2006 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 202 KB

## Abstract magnified image A series of new benzoylquinoxaline derivatives (**7‐26**) was synthesized and evaluated for antitumor activity against a panel of 60 human cell lines at the NCI of Bethesda. Among the compounds which have passed the preliminary screening, compound **23** exhibited the b